SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Becton, Dickinson and Company - BDX
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: GlobeNewswire
NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Becton, Dickinson and Company (“Becton” or the “Company”) (NYSE: BDX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Becton and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On February 6, 2020, Becton lowered its fiscal 2020 guidance, announcing that the Company expected revenue to increase by only 1.5% to 2.5%, “to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system.” According to Becton, the software remediation plan for the Company’s Alaris system “will require additional regulatory filings,” and existing customers would have “access to the Alaris System under medical necessity.” Becton f
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Closed System Transfer Devices Market Size Expected to Reach USD 5.39 Bn by 2033 | Expansion of Oncology and Infusion Services [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA [Yahoo! Finance]Yahoo! Finance
- Becton, Dickinson and Company (NYSE: BDX) had its price target raised by analysts at Barclays PLC from $305.00 to $312.00. They now have an "overweight" rating on the stock.MarketBeat
- Injectable Drug Delivery Market Worth $1139.4 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 5/2/24 - Beat
BDX
Sec Filings
- 5/6/24 - Form 4
- 5/6/24 - Form 4
- 5/2/24 - Form S-3ASR
- BDX's page on the SEC website